Content Type: Research Publications

Persistence of Resistance: A Panel Data Analysis of the Effect of Antibiotic Usage on the Prevalence of Resistance

March 6, 2026

Federal Funding for Discovery and Development of Costly HIV Drugs Was Far More Than Previously Estimated

March 6, 2026

Medicare Price Negotiation: The Example of Ibrutinib

March 6, 2026

Medicaid Spending on Antiretrovirals From 2007 Through 2019

March 6, 2026

Analysis of Risk Evaluation and Mitigation Strategies for Teratogenic Drugs: Variation in Primary and Secondary Prevention Measures

March 6, 2026

The $5 Billion Hop: Glatiramer Acetate and the US Patent System

March 6, 2026

A Methodology for Estimating Medicaid and Non-Medicaid Net Prices Using Top Brand-Name Drugs, 2015-2019

March 6, 2026

Timing of Confirmatory Trials for Drugs Granted Accelerated Approval Based on Surrogate Measures From 2012 to 2021

March 6, 2026

Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-Name Drugs Incorporating Best Price Rebates, 2015 to 2019

March 6, 2026

Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021

March 6, 2026

Sources of Innovation in Gene Therapies—Approaches to Achieving Affordable Prices

March 6, 2026

Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022

March 6, 2026